EXACT Therapeutics Investor Relations Material

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company headquartered in Oslo, Norway. The company is pioneering a novel ultrasound-mediated technology platform called Acoustic Cluster Therapy (ACT). This approach aims to significantly enhance the clinical utility of a wide range of therapeutic agents for a variety of applications, including oncology (both chemotherapy and immunotherapy), neurological conditions, and gene therapy. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange.